Literature DB >> 13583097

Enhanced susceptibility of proliferating endothelium to salivary gland virus under naturally occurring and experimental conditions.

F S VOGEL.   

Abstract

Keywords:  VIRUS DISEASES/pathology

Mesh：

Year:  1958        PMID： 13583097      PMCID： PMC1934799     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  8 in total

1.  Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease.

Authors:  M G SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

2.  Interaction of a salivary gland virus and experimentally produced carcinomas of the mouse salivary gland.

Authors:  W H BAUER; N G GRAND
Journal:  Cancer Res       Date:  1954-11       Impact factor: 12.701

3.  Spontaneous salivary gland virus disease in chimpanzees.

Authors:  F S VOGEL; H PINKERTON
Journal:  AMA Arch Pathol       Date:  1955-09

4.  Disseminated cytomegalic inclusion disease in an adult; with primary refractory anemia and transfusional siderosis; report of a case.

Authors:  J P WYATT; F A HEMSATH; M D SOASH
Journal:  Am J Clin Pathol       Date:  1951-01       Impact factor: 2.493

5.  New features of inclusion disease of infancy.

Authors:  W A WORTH; H L HOWARD
Journal:  Am J Pathol       Date:  1950-01       Impact factor: 4.307

6.  Generalized cytomegalic inclusion disease.

Authors:  J P WYATT; J SAXTON
Journal:  J Pediatr       Date:  1950-03       Impact factor: 4.406

7.  The Occurrence of Intranuclear Inclusions in Monkeys Unaccompanied by Specific Signs of Disease.

Authors:  W P Covell
Journal:  Am J Pathol       Date:  1932-03       Impact factor: 4.307

8.  Intranuclear and Cytoplasmic Inclusions ("Protozoan-Like Bodies") in the Salivary Glands and Other Organs of Infants.

Authors:  S Farber; S B Wolbach
Journal:  Am J Pathol       Date:  1932-03       Impact factor: 4.307
  8 in total
  16 in total

1.  Myocarditis complicating cytomegalovirus mononucleosis.

Authors:  S G Ball; G J Archer
Journal:  Postgrad Med J       Date:  1976-02       Impact factor: 2.401

2.  Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis.

Authors:  D J Lang
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Latent cytomegalovirus infection in blood donors.

Authors:  P Diosi; E Moldovan; N Tomescu
Journal:  Br Med J       Date:  1969-12-13

4.  Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy.

Authors:  I A Eyre-Brook; S Dundas
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

5.  Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

Authors:  N D Francis; A W Boylston; A H Roberts; J M Parkin; A J Pinching
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

6.  Primary cytomegalovirus infection and gastric ulcers in normal host.

Authors:  D O Arnar; G Gudmundsson; A Theodors; G Valtysson; A Sigfusson; J G Jonasson
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

7.  The pathogenesis of Aleutian disease of mink. 3. Immune complex arteritis.

Authors:  D D Porter; A E Larsen; H G Porter
Journal:  Am J Pathol       Date:  1973-05       Impact factor: 4.307

8.  Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells.

Authors:  W J Waldman; W H Roberts; D H Davis; M V Williams; D D Sedmak; R E Stephens
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Myocardial aneurysm in association with disseminated cytomegalovirus infection.

Authors:  G R Sánchez; W H Neches; R Jaffe
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

10.  Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome.

Authors:  E Rene; C Marche; T Chevalier; C Rouzioux; B Regnier; A G Saimot; Y Negesse; S Matheron; C Leport; B Wolff
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.